Evidence map›Paper›PMID 40593667›Full record

ArticleNature communications2025

Multidimensional third-generation sequencing of modified DNA bases allows interrogation of complex biological systems.

Serena S David, Brendan A Pacheco, Kensei Kishimoto, Sam Vantine, Kai Hu, Haibo Liu, Diana L Davis, Hoang Tran, Benjamin F Sallis, Levi Ali and 4 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Serena S David *Department of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA, USA.ORCID http://orcid.org/0000-0003-3175-326X
Brendan A Pacheco *Department of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA, USA.ORCID http://orcid.org/0009-0007-7072-824X
Kensei KishimotoDepartment of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA, USA.ORCID http://orcid.org/0000-0002-0745-1969
Sam VantineDepartment of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA, USA.ORCID http://orcid.org/0000-0003-3709-4146
Kai HuDepartment of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA, USA.ORCID http://orcid.org/0000-0002-6555-2581
Haibo LiuDepartment of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Diana L DavisDepartment of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Hoang TranDepartment of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Benjamin F SallisDepartment of Microbiology, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Levi AliDepartment of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Cole M HaynesDepartment of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA, USA.ORCID http://orcid.org/0000-0003-2110-5648
Beth A McCormickDepartment of Microbiology, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Lihua Julie ZhuDepartment of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA, USA.ORCID http://orcid.org/0000-0001-7416-0590
William A FlavahanDepartment of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA, USA. william.flavahan@umassmed.edu.ORCID http://orcid.org/0000-0002-9197-5764

Funding

Expanding the capabilities of third-generation sequencing for multi-dimensional genome and transcriptome analysis.DP2GM159179 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI FLAVAHAN, WILLIAM ALEXANDER · 2024 to 2024
$1.5M
Pathological epigenetic hyper-plasticity promotes acquisition of pro-tumor states in cancerK22CA237846 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI FLAVAHAN, WILLIAM ALEXANDER · 2020 to 2022
$601k
NCI NIH HHS K22 CA237846NIGMS NIH HHS DP2 GM159179Sontag Foundation Distinguished Scientist Award
6 · The paper itself

Abstract

DNA exists biologically as a highly dynamic macromolecular complex subject to myriad chemical modifications that alter its physiological interpretation, yet most sequencing technologies only measure Watson-Crick base pairing interactions. Third-generation sequencing technologies can directly detect novel and modified bases, yet the difficulty and cost of training these techniques for each novel base has so far limited this potential. Here, we present a method based on barcoded split-pool synthesis to generate reference standard oligonucleotides allowing novel base sequencing. Using novel base detection, we perform multidimensional sequencing to retrieve information, both physiologically stored and experimentally encoded, from DNA, allowing us to characterize the preferential replication of deleterious mitochondrial genome mutations, the infection dynamics of a host-pathogen model, and the effect of chemotherapy on cancer cell DNA at the single molecule level. The low cost and experimental simplicity of this method make this approach widely accessible to the research community, enabling complex experimental interrogation across the biological sciences.

Indexed as

DNAHigh-Throughput Nucleotide SequencingSequence Analysis, DNABase PairingCell Line, TumorDNA, MitochondrialGenome, MitochondrialHumansMutationOligonucleotidesDNADNA, MitochondrialOligonucleotides

Identifiers

PMID40593667
PMCPMC12215381

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.